Significant and continuous improvement in bone mineral density among type 1 Gaucher disease patients treated with velaglucerase alfa: 69-month experience, including dose reduction

Deborah Elstein, A. Joseph Foldes, David Zahrieh, Gabriel M. Cohn, Maja Djordjevic, Costin Brutaru, Ari Zimran

Research output: Contribution to journal › Article › peer-review

33 Scopus citations

Fingerprint

Dive into the research topics of 'Significant and continuous improvement in bone mineral density among type 1 Gaucher disease patients treated with velaglucerase alfa: 69-month experience, including dose reduction'. Together they form a unique fingerprint.

Medicine & Life Sciences